Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Reproductive Health topic

No spam. Unsubscribe anytime.

Senate subcommittee hears hours of split testimony on S 10 95; panel to reconvene

South Carolina Senate Medical Affairs Subcommittee · April 14, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Supporters urged S 10 95 be strengthened to grant personhood from fertilization; doctors, pharmacists and advocates warned the bill would criminalize patients and complicate access to mifepristone and misoprostol, potentially worsening maternal care in rural counties. The panel recessed and will reconvene at 9 a.m. tomorrow.

The South Carolina Senate Medical Affairs Subcommittee heard more than three hours of testimony on Senate Bill S 10 95, with witnesses sharply divided over whether the measure properly balances protections for the preborn and practical medical, legal and logistical concerns for patients and providers.

Supporters, including representatives of Personhood and Equal Protection groups, urged the subcommittee to strengthen S 10 95 or adopt personhood language that would define a person "beginning at fertilization." Steve Lefferman of Christians for Personhood asked the committee to insert language from a House personhood bill, saying the change would "establish justice and ultimately end and abolish all decriminalized child murder by abortion in South Carolina." Pastor Mark Corral of Equal Protection South Carolina argued that current and proposed incremental laws leave too many preborn children unprotected and urged penalties equivalent to homicide for willful killing of a preborn child.

Medical and public-health witnesses, however, warned that the bill as written would have serious unintended consequences. Dr. Elizabeth Nodleman, a board-certified OB-GYN and residency program director in Columbia, said the bill would function as a total abortion ban and "equates abortion to homicide," while also restricting access to medications commonly used for miscarriage care and postpartum hemorrhage. "This bill will hurt real mothers of our state," she said, adding that her program recruited no students from South Carolina this year and that workforce shortages already leave 17 counties without an OB-GYN.

Pharmacists and pharmacy association representatives testified that S 10 95 would reclassify mifepristone and misoprostol as Schedule IV controlled substances and require diagnosis codes on prescriptions, creating new inventory, dispensing and documentation steps that could delay care. Mariana Wilbur, a licensed pharmacist, said the proposed classification would add "legal ambiguity and encourage defensive inconsistent dispensing decisions," particularly in rural settings where wholesalers and staffing are limited.

Advocates for patients also emphasized social and practical harms. Ashlyn Pro, cofounder of the Palmetto State Abortion Fund, said the bill "criminalizes patients and people who help them," including volunteers and family members who assist with travel or lodging. Public commenters and clergy framed the measure as both a religiously infused policy and a public-health risk, citing peer-reviewed studies and data from the March of Dimes and Kaiser Family Foundation tying restrictive laws to worse infant and maternal outcomes.

Senators pressed witnesses on specifics: several asked clinicians how often the medications at issue are prescribed for abortion versus miscarriage or hemorrhage; physicians and pharmacists provided clinical context but said statewide percentages were not available during the hearing. Supporters pressed on moral and legal consistency — some urged extending equal protection from fertilization — while others questioned the political feasibility of harsher penalties after prior measures failed.

No formal action or votes were taken. The chair said the public-comment list had been exhausted and announced the subcommittee would reconvene at 9 a.m. the following day to resume consideration of S 10 95.

The hearing included extensive exchanges between witnesses and senators, with testimony from physicians, pharmacists, clergy, patient advocates and volunteer organizations on both sides of the issue. The subcommittee did not advance the bill before adjourning.